A detailed history of Front Row Advisors LLC transactions in Idexx Laboratories Inc stock. As of the latest transaction made, Front Row Advisors LLC holds 61 shares of IDXX stock, worth $29,151. This represents 0.01% of its overall portfolio holdings.

Number of Shares
61
Previous 40 52.5%
Holding current value
$29,151
Previous $22,000 45.45%
% of portfolio
0.01%
Previous 0.01%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$515.08 - $576.87 $10,816 - $12,114
21 Added 52.5%
61 $32,000
Q4 2023

Feb 15, 2024

SELL
$391.37 - $557.56 $32,875 - $46,835
-84 Reduced 67.74%
40 $22,000
Q3 2023

Nov 15, 2023

SELL
$432.42 - $556.67 $1.48 Million - $1.9 Million
-3,421 Reduced 96.5%
124 $54,000
Q2 2023

Aug 14, 2023

SELL
$450.7 - $503.61 $108,168 - $120,866
-240 Reduced 6.34%
3,545 $1.78 Million
Q1 2023

May 22, 2023

BUY
$406.01 - $514.59 $768,170 - $973,604
1,892 Added 99.95%
3,785 $1.89 Million
Q1 2023

May 15, 2023

SELL
$406.01 - $514.59 $799,839 - $1.01 Million
-1,970 Reduced 51.0%
1,893 $379,000
Q4 2022

Feb 15, 2023

SELL
$324.64 - $441.27 $30,191 - $41,038
-93 Reduced 2.35%
3,863 $1.58 Million
Q3 2022

Nov 15, 2022

SELL
$325.8 - $407.78 $6,190 - $7,747
-19 Reduced 0.48%
3,956 $1.29 Million
Q2 2022

Aug 15, 2022

SELL
$327.37 - $553.44 $1,636 - $2,767
-5 Reduced 0.13%
3,975 $1.39 Million
Q1 2022

May 11, 2022

BUY
$466.52 - $631.01 $3,732 - $5,048
8 Added 0.2%
3,980 $2.18 Million
Q4 2021

Mar 09, 2022

SELL
$586.54 - $666.48 $354,270 - $402,553
-604 Reduced 13.2%
3,972 $2.62 Million
Q3 2021

Nov 03, 2021

BUY
$621.9 - $705.76 $21,766 - $24,701
35 Added 0.77%
4,576 $2.85 Million
Q2 2021

Aug 23, 2021

SELL
$486.36 - $637.08 $88,031 - $115,311
-181 Reduced 3.83%
4,541 $3.1 Million
Q1 2021

Apr 28, 2021

BUY
$465.18 - $551.79 $27,910 - $33,107
60 Added 1.29%
4,722 $2.31 Million
Q4 2020

Feb 25, 2021

SELL
$383.85 - $499.87 $34,546 - $44,988
-90 Reduced 1.89%
4,662 $2.33 Million
Q3 2020

Nov 30, 2020

SELL
$334.54 - $406.31 $55,868 - $67,853
-167 Reduced 3.39%
4,752 $2.16 Million
Q2 2020

Aug 17, 2020

SELL
$230.66 - $330.16 $38,520 - $55,136
-167 Reduced 3.28%
4,919 $1.62 Million
Q1 2020

May 08, 2020

BUY
$182.94 - $290.97 $80,493 - $128,026
440 Added 9.47%
5,086 $1.41 Million
Q4 2019

Feb 14, 2020

BUY
$248.66 - $285.01 $16,162 - $18,525
65 Added 1.42%
4,646 $1.21 Million
Q3 2019

Nov 08, 2019

SELL
$260.07 - $289.93 $49,413 - $55,086
-190 Reduced 3.98%
4,581 $1.25 Million
Q2 2019

Aug 27, 2019

BUY
$215.53 - $275.33 $21,337 - $27,257
99 Added 2.12%
4,771 $1.31 Million
Q1 2019

May 17, 2019

SELL
$178.02 - $225.69 $12,283 - $15,572
-69 Reduced 1.46%
4,672 $1.05 Million
Q4 2018

Feb 13, 2019

BUY
$176.18 - $248.92 $14,094 - $19,913
80 Added 1.72%
4,741 $882,000
Q3 2018

Nov 13, 2018

SELL
$218.82 - $254.46 $13,566 - $15,776
-62 Reduced 1.31%
4,661 $965,000
Q2 2018

Jul 31, 2018

BUY
$185.56 - $227.9 $30,988 - $38,059
167 Added 3.67%
4,723 $1.19 Million
Q1 2018

May 21, 2018

BUY
$157.81 - $204.73 $63,913 - $82,915
405 Added 9.76%
4,556 $872,000
Q4 2017

Feb 01, 2018

BUY
$147.68 - $168.37 $613,019 - $698,903
4,151
4,151 $649,000

Others Institutions Holding IDXX

About IDEXX LABORATORIES INC


  • Ticker IDXX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 83,253,696
  • Market Cap $39.8B
  • Description
  • IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, inclu...
More about IDXX
Track This Portfolio

Track Front Row Advisors LLC Portfolio

Follow Front Row Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Front Row Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Front Row Advisors LLC with notifications on news.